Omega-3 Market

研究執行與發布：MarketsandMarkets　·　發布日期 2026-07-20　·　326 頁
由量子訊息有限公司（Quantum Information）在台灣代理銷售與提供授權諮詢。

完整報告名稱與涵蓋範圍

Omega-3 Market by Type (DHA, EPA, & ALA), Source (Marine & Plant), Application (Dietary Supplements, Functional Foods & Beverages, Pharmaceuticals, Infant Formulas, and Pet Food & Feed), Form, Manufacturing Technology, and Region - Global Forecast to 2031

報告摘要

The omega-3 market is estimated to be USD 4.88 billion in 2026 and is projected to reach USD 8.73 billion by 2031, at a CAGR of 12.3%. The omega-3 market is gaining significant traction, driven by the increasing recognition of the roles of EPA and DHA in cardiovascular health, cognitive function, vision, joint health, and infant brain development, as well as a growing consumer shift toward preventive healthcare and functional nutrition. The infant formula sector has witnessed explosive growth, driven by rising awareness among parents about the importance of early nutrition for cognitive and physical development, particularly the role of DHA and other essential nutrients, and regulatory mandates and recommendations in regions such as Europe, North America, and China requiring or encouraging DHA fortification in infant formula. However, high costs involved in R&D activities and unstable fish oil prices are expected to pose a challenge to the omega-3 market’s growth. Disruptions in the omega-3 market may offer opportunities for players The omega-3 market is undergoing fundamental shifts, opening up new opportunities for companies. One of the most significant changes is the shift toward sustainable and plant-based sources such as algal oil and fermentation-based omega-3, which eliminate fish oil supply concerns and resonate with vegan and green consumers. Regulatory updates, such as the mandatory fortification of DHA in infant nutrition and broader approvals for cardiovascular and cognitive well-being claims, are also driving steady demand in both developed and emerging markets. Meanwhile, technological advances such as microencapsulation are enhancing stability and flavor, allowing omega-3 to be incorporated in new food and beverage applications. On the application front, Omega-3 is increasingly being used in pharmaceuticals, pet food, and aquaculture, apart from conventional supplements. Pharma-grade formulations for neurological and cardiovascular health are gaining momentum, while high-end pet food and fortified aquaculture feed are experiencing significant growth. Alongside growing demand for convenience formats of functional nutrition products (gummies, powders, RTDs) and increasing consumer spending on health supplement products in South America and the Asia Pacific, these trends are redefining the landscape of the market. Players who innovate in sourcing, product development, and sustainability have a good chance of securing growth in emerging markets. The dietary supplement segment is projected to be one of the fastest-growing segments The dietary supplement category is one of the major growth drivers for the omega-3 market as consumers place greater emphasis on preventive healthcare and turn to convenient solutions for heart, brain, eye, and joint well-being. Supported by regulatory approvals for health claims, supplements offer confidence and convenience, as advancements in delivery forms, such as softgels, gummies, and powders, make them attractive to people of all ages. This synergy of health consciousness, aging population, and product creativity is driving robust and consistent demand for omega-3 in dietary supplements. The liquid form of omega-3 is expected to hold a larger share of the omega-3 market The majority of commercial omega-3 comes from fish oil, algal oil, and krill oil, which are naturally liquid forms and commonly used in dietary supplements, infant formula, functional foods, and pharmaceuticals. Liquids can accommodate higher purity, greater bioavailability, and simpler inclusion in soft gels, emulsions, and fortified liquid food. While dry formulations (powders, microencapsulated omega-3) are increasing as a result of uses in gummies, powders, and bakery applications, the liquid form continues to hold a significant market share as it is the most cost-efficient, mass-produced, and immediately applicable state across industries. The eicosapentaenoic acid (EPA) segment is expected to grow at a significant rate The EPA has been shown to benefit heart health, including reducing triglyceride levels, decreasing inflammation, and improving overall cardiovascular function. As awareness of these health benefits increases among consumers, there is a growing demand for omega-3 supplements and fortified foods and beverages containing EPA, which contributes to the expansion of the omega-3 market. The US is estimated to dominate the North American omega-3 market during the forecast period The US is one of the largest global markets for omega-3. The consumption of omega-3-based products and supplements has increased significantly due to rising consumer awareness of their various health benefits and their availability in the US market. The omega-3 consumption pattern in the US is driven toward categories such as capsules, dietary supplements, and infant formula. However, the country has one of the largest consumer markets in the world. Recently, the EPA/DHA (omega-3) ingredients sector has experienced a surge in product innovations, introducing new omega-3 variants and expanding the utilization of plant-based sources. As consumers increasingly prioritize the health of oceans, there is a growing demand for plant-based omega-3 ingredients within the dietary supplement sector. In-depth interviews have been conducted with chief executive officers (CEOs), directors, and other executives from various key organizations operating in the omega-3 market. • By Company Type: Tier 1 – 30%, Tier 2 – 25%, and Tier 3 – 45% • By Designation: CXOs – 25%, Managers – 40%, Executives – 35% • By Region: North America – 22%, Europe – 28%, Asia Pacific – 32%, South America – 10%, and Rest of the World – 8% Prominent companies in the market include BASF SE (Germany), Cargill, Incorporated (US), DSM-Firmenich (Netherlands), ADM (US), Kerry Group plc (Ireland), Aker BioMarine (Norway), Croda International PLC (UK), Corbion (Netherlands), Pelagia AS (Norway), KD Pharma Group SA (Switzerland), GC Rieber (Norway), Cooke Aquaculture Inc. (Canada), GOLDEN OMEGA (Chile), Polaris (France), Btsa (Spain), KinOmega Biopharm Inc. (China), Rimfrost AS (Norway), Mara Renewables (Canada), Cellana Inc. (US), and AlgaeCytes Limited (UK). Research Coverage This research report categorizes the omega-3 market by type (docosahexaenoic acid (DHA), eicosapentaenoic acid (EPA), and alpha-linolenic acid (ALA)), source (marine [fish, algal, krill, and other marine sources] and plant [nuts & seeds and vegetable oils]), application (dietary supplements, functional foods & beverages, pharmaceuticals, infant formulas, and pet food and feed), form (dry and liquid), manufacturing technology (qualitative) (extraction, refining & purification, concentration & conversion, encapsulation & stabilization, and fermentation & biotechnology), and region (North America, Europe, Asia Pacific, South America, and Rest of the World). The scope of the report covers detailed information regarding the major factors, such as drivers, restraints, challenges, and opportunities, influencing the growth of omega-3 ingredients. A thorough analysis of the key industry players has been done to provide insights into their business, services, key strategies, contracts, partnerships, agreements, product launches, mergers & acquisitions, and recent developments associated with the omega-3 market. This report covers the competitive analysis of upcoming startups in the omega-3 market ecosystem. Furthermore, the study covers industry-specific trends, including technology analysis, ecosystem & market mapping, and patent & regulatory landscapes, among others. Reasons to Buy This Report The report offers market leaders/new entrants information on the closest approximations of the revenue numbers for the overall omega-3 and subsegments. It will help stakeholders understand the competitive landscape and gain more insights to better position their businesses and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, challenges, and opportunities. The report provides insights into the following pointers: • Analysis of key drivers (Rising adoption of algal oil and plant-based omega-3 (flaxseed, chia, canola) due to concerns over fish oil sustainability), restraints (lack of clarity among consumers about daily recommended intake and health claims), opportunities (increase in research for development of alternative sources to obtain omega-3), and challenges (highly unstable fish oil prices) influencing the growth of the omega-3 market • Product Development/Innovation: Detailed insights on research & development activities and new product launches in the omega-3 market • Market Development: Comprehensive information about lucrative markets—the report analyzes omega-3 across varied regions • Market Diversification: Exhaustive information about new product sources, untapped geographies, recent developments, and investments in the omega-3 market • Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings, brand/product comparison, and product footprints of leading players such as BASF SE (Germany), Cargill, Incorporated (US), DSM-Firmenich (Netherlands), ADM (US), Kerry Group plc (Ireland), Aker BioMarine (Norway), Croda International PLC (UK), Corbion (Netherlands), Pelagia AS (Norway), KD Pharma Group SA (Switzerland), and other players in the omega-3 market

授權報價

Single User Licence	$4,950 USD
Multi User Licence	$6,650 USD
Corporate User Licence	$8,150 USD
Global User Licence	$10,000 USD

目錄 Table of Contents

1 INTRODUCTION 29 1.1 STUDY OBJECTIVES 29 1.2 MARKET DEFINITION 29 1.3 STUDY SCOPE 30 1.3.1 MARKETS COVERED AND REGIONS CONSIDERED 30 1.3.2 INCLUSIONS AND EXCLUSIONS 31 1.3.3 YEARS CONSIDERED 32 1.3.4 CURRENCY CONSIDERED 32 1.3.5 UNITS CONSIDERED 33 1.4 STAKEHOLDERS 33 1.5 SUMMARY OF CHANGES 34 2 EXECUTIVE SUMMARY 35 2.1 MARKET HIGHLIGHTS AND KEY INSIGHTS 35 2.2 KEY MARKET PARTICIPANTS: MAPPING OF STRATEGIC DEVELOPMENTS 37 2.3 DISRUPTIVE TRENDS IN OMEGA-3 MARKET 38 2.4 HIGH-GROWTH SEGMENTS 39 2.5 REGIONAL SNAPSHOT: MARKET SIZE, GROWTH RATE, AND FORECAST 40 3 PREMIUM INSIGHTS 41 3.1 ATTRACTIVE OPPORTUNITIES FOR PLAYERS IN OMEGA-3 MARKET 41 3.2 OMEGA-3 MARKET, BY TYPE AND REGION 42 3.3 OMEGA-3 MARKET, BY 3 TYPES 42 3.4 OMEGA-3 MARKET, BY SOURCE 43 3.5 OMEGA-3 MARKET, BY FORM 43 3.6 OMEGA-3 MARKET, BY APPLICATION 43 3.7 OMEGA-3 MARKET, BY COUNTRY 44 4 MARKET OVERVIEW 45 4.1 INTRODUCTION 45 4.2 MARKET DYNAMICS 46 4.2.1 DRIVERS 46 4.2.1.1 Growing consumer awareness regarding health benefits 46 4.2.1.2 Increasing use in food and feed products 48 4.2.1.2.1 Rising demand for mother and infant nutrition products 48 4.2.1.2.2 Mandatory inclusion of algal DHA in infant formula 48 4.2.1.2.3 Growth focus of food processing companies on fortification 48 4.2.1.2.4 Increasing applications in pet food and feed 49 4.2.1.3 Shift toward pharmaceutical-grade high-concentrate omega-3 oils in developed markets 50 4.2.1.4 Emergence of innovative production technologies 50 4.2.2 RESTRAINTS 52 4.2.2.1 Declining fish oil supply due to sustainability issues in fisheries 52 4.2.2.2 Lack of clarity on daily intake recommendations and health claims 53 4.2.3 OPPORTUNITIES 53 4.2.3.1 Increasing research on alternative sources 53 4.2.3.1.1 Rising consumer demand for plant-based products 54 4.2.3.1.2 Growing focus on microalgae-based omega-3 production 55 4.2.3.1.3 Side effects and allergies related to fish-based products 55 4.2.3.2 Favorable regulatory environment 56 4.2.3.3 Integration of microencapsulation technology 56 4.2.4 CHALLENGES 57 4.2.4.1 High costs involved in R&D activities 57 4.2.4.2 Volatility in fish oil prices 57 4.2.4.3 Instability of omega-3 oils 58 4.3 UNMET NEEDS AND WHITE SPACES 58 4.3.1 UNMET NEEDS IN THE OMEGA 3 MARKET 58 4.3.2 WHITE SPACE OPPORTUNITIES 59 4.4 INTERCONNECTED MARKETS AND CROSS-SECTOR OPPORTUNITIES 60 4.4.1 INTERCONNECTED MARKETS 60 4.4.2 CROSS SECTOR OPPORTUNITIES 61 4.5 STRATEGIC MOVES BY TIER-1/2/3 PLAYERS 62 5 INDUSTRY TRENDS 63 5.1 PORTER’S FIVE FORCES ANALYSIS 63 5.1.1 INTENSITY OF COMPETITIVE RIVALRY 64 5.1.2 BARGAINING POWER OF SUPPLIERS 64 5.1.3 BARGAINING POWER OF BUYERS 64 5.1.4 THREAT OF SUBSTITUTES 65 5.1.5 THREAT OF NEW ENTRANTS 65 5.2 MACROECONOMIC OUTLOOK 65 5.2.1 INTRODUCTION 65 5.3 MACROECONOMIC INDICATORS 65 5.3.1 SUSTAINABILITY AND CIRCULAR ECONOMY INITIATIVES 65 5.3.2 PREVENTIVE HEALTHCARE EXPENDITURE 66 5.3.3 GROWING GERIATRIC POPULATION 67 5.4 VALUE CHAIN ANALYSIS 68 5.4.1 RESEARCH AND PRODUCT DEVELOPMENT 68 5.4.2 SOURCING 69 5.4.3 PRODUCTION AND PROCESSING 69 5.4.4 DISTRIBUTION 69 5.4.5 MARKETING AND SALES 69 5.4.6 END USERS 69 5.5 ECOSYSTEM ANALYSIS 70 5.5.1 DEMAND SIDE 70 5.5.2 SUPPLY SIDE 70 5.6 PRICING ANALYSIS 72 5.6.1 INTRODUCTION 72 5.6.2 AVERAGE SELLING PRICE OF OMEGA-3 FINISHED PRODUCTS, BY PRODUCT TYPE 72 5.6.3 AVERAGE SELLING PRICE (ASP) TREND, BY REGION 73 5.6.4 AVERAGE SELLING PRICE (ASP) TREND, BY SOURCE 74 5.7 TRADE ANALYSIS 75 5.7.1 IMPORT ANALYSIS: OMEGA-3 75 5.7.2 EXPORT ANALYSIS: OMEGA-3 76 5.8 KEY CONFERENCES AND EVENTS, 2026–2027 77 5.9 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 78 5.10 INVESTMENT AND FUNDING SCENARIO 78 5.11 CASE STUDY ANALYSIS 79 5.11.1 MIALGAE INTRODUCED SUSTAINABLE OMEGA-3 PRODUCTION WITH INNOVATIVE BIOTECHNOLOGY 79 5.11.2 KD PHARMA GROUP: ADVANCING PHARMACEUTICAL-GRADE OMEGA-3 PURIFICATION TECHNOLOGIES 79 5.11.3 VERAMARIS: PIONEERING SUSTAINABLE OMEGA-3 SOLUTIONS IN AQUACULTURE 80 5.11.4 DSM-FIRMENICH: EXPANDING ALGAE-DERIVED DHA ACROSS LIFE-STAGE NUTRITION 80 5.11.5 AKER BIOMARINE EXPANDED EUROPEAN MARKET ACCESS THROUGH STRATEGIC DISTRIBUTION PARTNERSHIPS 81 5.12 IMPACT OF 2025 US TARIFFS - OMEGA-3 MARKET 81 5.12.1 INTRODUCTION 81 5.12.2 PRICE IMPACT ANALYSIS 82 5.12.3 IMPACT ON COUNTRIES/REGIONS 82 5.12.3.1 US 82 5.12.3.2 Europe 82 5.12.3.3 Asia Pacific 82 5.12.4 IMPACT ON END-USE INDUSTRIES 83 6 TECHNOLOGY ADVANCEMENTS, AI-DRIVEN IMPACT, PATENTS, INNOVATIONS, AND FUTURE APPLICATIONS 84 6.1 TECHNOLOGY ANALYSIS 84 6.1.1 KEY TECHNOLOGIES 84 6.1.1.1 Molecular distillation 84 6.1.1.2 Supercritical CO₂ extraction 85 6.1.1.3 Algae fermentation 85 6.1.2 COMPLEMENTARY TECHNOLOGIES 86 6.1.2.1 Stabilization & antioxidant technologies 86 6.1.2.2 Microencapsulation 86 6.1.3 ADJACENT TECHNOLOGIES 86 6.1.3.1 Precision fermentation 86 6.1.3.2 Synthetic biology & bioprocess engineering 87 6.1.4 TECHNOLOGY/PRODUCT ROADMAP 87 6.1.4.1 Short-Term | High-Purity Omega-3 Production & Stability Enhancement 87 6.1.4.2 Mid-Term | Sustainable EPA & DHA Manufacturing 87 6.1.4.3 Long-Term | Precision Nutrition & Next-Generation Omega-3 Innovation 87 6.2 PATENT ANALYSIS 88 6.3 FUTURE APPLICATIONS 89 6.3.1 CLINICAL NUTRITION & HEALTHY AGING: EXPANDING THE FUTURE OF OMEGA-3 APPLICATIONS 90 6.3.2 STABLE DHA-ENRICHED FUNCTIONAL FOODS: ADVANCING THE NEXT GENERATION OF OMEGA-3 NUTRITION 90 6.3.3 PLANT-BASED OMEGA-3 SUPPLEMENTATION: ENABLING THE FUTURE OF PERSONALIZED VEGAN NUTRITION 91 6.3.4 OMEGA-3 BIOMARKER-BASED PRENATAL NUTRITION: ENABLING PRECISION MATERNAL HEALTHCARE 91 6.4 IMPACT OF GENERATIVE AI ON OMEGA 3 MARKET 92 6.4.1 INTRODUCTION 92 6.4.2 TOP USE CASES AND MARKET POTENTIAL 92 6.4.3 BEST PRACTICES IN OMEGA 3 INDUSTRY 93 6.4.4 CASE STUDIES OF AI IMPLEMENTATION IN OMEGA 3 MARKET 93 6.4.5 INTERCONNECTED ADJACENT ECOSYSTEM AND IMPACT ON MARKET PLAYERS 94 6.4.6 CLIENTS’ READINESS TO ADOPT GENERATIVE AI FOR OMEGA 3 PRODUCTION 94 6.5 SUCCESS STORIES AND REAL-WORLD APPLICATIONS 95 7 SUSTAINABILITY AND REGULATORY LANDSCAPE 96 7.1 REGIONAL REGULATIONS AND COMPLIANCE 96 7.1.1 INDUSTRY STANDARDS 99 7.1.2 LABELING REQUIREMENTS AND CLAIMS 100 7.1.3 ANTICIPATED REGULATORY CHANGES IN NEXT 5-10 YEARS 101 7.1.3.1 Enhanced Traceability and Sustainability Requirements 101 7.1.3.2 Global Harmonization of Omega-3 Labeling and Health Claims 101 7.1.3.3 Stricter Quality, Purity, and Contaminant Standards 101 7.1.3.4 Digital Traceability, AI-Enabled Quality Monitoring, and Compliance Automation 101 7.1.3.5 Stronger Sustainability and ESG Compliance Requirements 101 7.2 SUSTAINABILITY INITIATIVES 101 7.2.1 SUSTAINABLE SOURCING 102 7.2.2 CARBON FOOTPRINT REDUCTION INITIATIVES 102 7.2.3 CIRCULAR ECONOMY APPROACHES 103 7.3 SUSTAINABILITY IMPACT AND REGULATORY POLICY INITIATIVES 103 7.4 CERTIFICATIONS, LABELING, ECO-STANDARDS 103 8 CUSTOMER LANDSCAPE AND BUYER BEHAVIOR 105 8.1 DECISION-MAKING PROCESS 105 8.2 KEY STAKEHOLDERS AND BUYING CRITERIA 107 8.2.1 KEY STAKEHOLDERS IN BUYING PROCESS 107 8.2.2 BUYING CRITERIA 108 8.3 ADOPTION BARRIERS AND INTERNAL CHALLENGES 109 8.4 UNMET NEEDS OF VARIOUS APPLICATION INDUSTRIES ACROSS SUPPLY CHAIN 110 8.5 MARKET PROFITABILITY 111 8.6 REVENUE POTENTIAL 112 8.6.1 COST DYNAMICS 112 9 OMEGA-3 MARKET, BY TYPE 114 9.1 INTRODUCTION 115 9.2 DOCOSAHEXAENOIC ACID 116 9.2.1 NEED FOR PROTECTION AGAINST ALZHEIMER'S DISEASE TO DRIVE DEMAND 116 9.3 EICOSAPENTAENOIC ACID 118 9.3.1 ABILITY TO REDUCE SUSCEPTIBILITY TO CARDIOVASCULAR DISEASES TO BOOST DEMAND 118 9.4 ALPHA-LINOLENIC ACID 119 9.4.1 GROWING POPULARITY AMONG VEGETARIANS AND VEGANS TO BOOST DEMAND 119 10 OMEGA-3 MARKET, BY SOURCE 121 10.1 INTRODUCTION 122 10.2 MARINE 123 10.2.1 NEED FOR HEALTHY FETAL DEVELOPMENT IN PREGNANT WOMEN TO DRIVE MARKET 123 10.2.2 FISH 126 10.2.2.1 Anchovy 127 10.2.2.2 Sardine 127 10.2.2.3 Mackerel 127 10.2.2.4 Other fish types 127 10.2.3 ALGAE 128 10.2.3.1 Schizochytrium sp. 128 10.2.3.2 Crypthecodinium cohnii 129 10.2.3.3 Nannochloropsis sp. 129 10.2.3.4 Other algae types 129 10.2.4 KRILL 129 10.2.5 OTHER MARINE SOURCES 130 10.3 PLANT 131 10.3.1 GROWING USE OF FLAX SEEDS FOR CANCER PREVENTION TO BOOST DEMAND 131 10.3.2 NUTS & SEEDS 133 10.3.3 VEGETABLE OILS 134 11 OMEGA-3 MARKET, BY APPLICATION 136 11.1 INTRODUCTION 137 11.2 DIETARY SUPPLEMENTS 138 11.2.1 GROWING IMPORTANCE OF BALANCED AND NUTRITIOUS DIETS TO DRIVE DEMAND 138 11.3 FUNCTIONAL FOODS & BEVERAGES 139 11.3.1 ABILITY TO BOOST CARDIOVASCULAR HEALTH TO DRIVE DEMAND 139 11.3.2 DAIRY & DAIRY ALTERNATIVES 140 11.3.3 BAKERY & CEREAL PRODUCTS 141 11.3.4 CONFECTIONERY PRODUCTS 141 11.3.5 MEAT & MEAT PRODUCTS 141 11.3.6 BEVERAGES 141 11.3.7 OTHER FUNCTIONAL FOOD PRODUCTS 142 11.4 PHARMACEUTICALS 142 11.4.1 GROWING NEED TO LOWER ELEVATED TRIGLYCERIDE LEVELS TO DRIVE MARKET 142 11.5 INFANT FORMULAS 143 11.5.1 RISING CONSUMPTION OF OMEGA-3 DHA DURING PREGNANCY TO BOOST DEMAND 143 11.6 PET FOOD & FEED 144 11.6.1 GREATER EMPHASIS ON ENHANCING IMMUNITY IN PETS TO DRIVE MARKET 144 11.6.2 PET FOOD 145 11.6.3 ANIMAL FEED 145 12 OMEGA-3 MARKET, BY FORM 146 12.1 INTRODUCTION 147 12.2 DRY 148 12.2.1 ENCAPSULATED STABILITY MEETS VERSATILE APPLICATIONS 148 12.3 LIQUID 149 12.3.1 HIGH BIOAVAILABILITY AND EFFICACY TO FUEL DEMAND 149 13 OMEGA 3 MARKET, BY MANUFACTURING TECHNOLOGY 151 13.1 INTRODUCTION 151 13.2 EXTRACTION 151 13.3 REFINING & PURIFICATION 151 13.4 CONCENTRATION & CONVERSION 152 13.5 ENCAPSULATION & STABILIZATION 152 13.6 FERMENTATION & BIOTECHNOLOGY 152 14 OMEGA-3 MARKET, BY REGION 154 14.1 INTRODUCTION 155 14.2 NORTH AMERICA 158 14.2.1 US 163 14.2.1.1 Growing incorporation of omega-3 in dietary supplements to drive market 163 14.2.2 CANADA 164 14.2.2.1 Increasing application in functional foods & beverages to boost market 164 14.2.3 MEXICO 166 14.2.3.1 Growing focus on heart disease prevention to drive market 166 14.3 EUROPE 168 14.3.1 GERMANY 172 14.3.1.1 Low fish consumption to boost demand for omega-3-based supplements 172 14.3.2 UK 173 14.3.2.1 Rising gastrointestinal health awareness supporting Omega-3 demand 173 14.3.3 FRANCE 175 14.3.3.1 Rising cardiovascular disease burden driving Omega-3 consumption 175 14.3.4 NORWAY 177 14.3.4.1 Production of genetically modified canola to offer lucrative growth opportunities to market players 177 14.3.5 ITALY 178 14.3.5.1 High production of dietary supplements, functional food products, and beverages to boost market 178 14.3.6 SPAIN 179 14.3.6.1 Rising consumer awareness and dietary gaps to drive market 179 14.3.7 NETHERLANDS 181 14.3.7.1 Growing incidences of depression, autism, and ADHD to drive market 181 14.3.8 REST OF EUROPE 182 14.4 ASIA PACIFIC 184 14.4.1 CHINA 189 14.4.1.1 Increasing focus on product innovations and diversification to drive market 189 14.4.2 INDIA 191 14.4.2.1 Growing incidences of heart failure to drive market 191 14.4.3 JAPAN 192 14.4.3.1 Rapidly aging population driving demand for Omega-3 supplements 192 14.4.4 AUSTRALIA & NEW ZEALAND 194 14.4.4.1 Government-led initiatives to increase awareness regarding omega-3 to drive market 194 14.4.5 REST OF ASIA PACIFIC 196 14.5 SOUTH AMERICA 197 14.5.1 BRAZIL 201 14.5.1.1 Rising demand for algal oils to drive market 201 14.5.2 ARGENTINA 203 14.5.2.1 Commercialization of omega-3 products to fuel market 203 14.5.3 REST OF SOUTH AMERICA 204 14.6 REST OF THE WORLD (ROW) 205 14.6.1 AFRICA 209 14.6.1.1 Prevalence of undernutrition among pregnant women and children to drive market 209 14.6.2 MIDDLE EAST 210 14.6.2.1 Ongoing innovations in omega-3 products to drive market 210 15 COMPETITIVE LANDSCAPE 212 15.1 OVERVIEW 212 15.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 212 15.3 REVENUE ANALYSIS 214 15.4 MARKET SHARE ANALYSIS 215 15.5 COMPANY VALUATION AND FINANCIAL METRICS 218 15.6 OMEGA-3 MARKET: BRAND/PRODUCT COMPARISON 219 15.7 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2025 220 15.7.1 STARS 221 15.7.2 EMERGING LEADERS 221 15.7.3 PERVASIVE PLAYERS 221 15.7.4 PARTICIPANTS 221 15.7.5 COMPANY FOOTPRINT: KEY PLAYERS 223 15.7.5.1 Company footprint 223 15.7.5.2 Regional footprint 223 15.7.5.3 Source footprint 224 15.7.5.4 Type footprint 225 15.7.5.5 Application footprint 225 15.8 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024 226 15.8.1 PROGRESSIVE COMPANIES 226 15.8.2 RESPONSIVE COMPANIES 226 15.8.3 DYNAMIC COMPANIES 226 15.8.4 STARTING BLOCKS 227 15.8.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024 228 15.9 COMPETITIVE SCENARIO AND TRENDS 230 15.9.1 OMEGA-3 MARKET: PRODUCT LAUNCHES 230 15.9.2 DEALS 231 15.9.3 EXPANSIONS 233 16 COMPANY PROFILES 234 16.1 KEY PLAYERS 234 16.1.1 DSM-FIRMENICH 234 16.1.1.1 Business overview 234 16.1.1.2 Products/Solutions/Services offered 235 16.1.1.3 Recent developments 236 16.1.1.3.1 Product launches and enhancements 236 16.1.1.4 MnM view 236 16.1.1.4.1 Key strengths 236 16.1.1.4.2 Strategic choices 236 16.1.1.4.3 Weaknesses and competitive threats 237 16.1.2 CARGILL, INCORPORATED 238 16.1.2.1 Business overview 238 16.1.2.2 Products/Solutions/Services offered 239 16.1.2.3 Recent developments 240 16.1.2.3.1 Deals 240 16.1.2.4 MnM view 240 16.1.2.4.1 Key strengths 240 16.1.2.4.2 Strategic choices 240 16.1.2.4.3 Weaknesses and competitive threats 240 16.1.3 BASF SE 241 16.1.3.1 Business overview 241 16.1.3.2 Products/Solutions/Services offered 242 16.1.3.3 Recent developments 243 16.1.3.3.1 Deals 243 16.1.3.4 MnM view 243 16.1.3.4.1 Key strengths 243 16.1.3.4.2 Strategic choices 243 16.1.3.4.3 Weaknesses and competitive threats 243 16.1.4 ADM 244 16.1.4.1 Business overview 244 16.1.4.2 Products/Solutions/Services offered 245 16.1.4.3 MnM view 246 16.1.4.3.1 Key strengths 246 16.1.4.3.2 Strategic choices 246 16.1.4.3.3 Weaknesses and competitive threats 246 16.1.5 KERRY GROUP PLC 247 16.1.5.1 Business overview 247 16.1.5.2 Products/Solutions/Services offered 248 16.1.5.3 Recent developments 249 16.1.5.3.1 Deals 249 16.1.5.4 MnM view 249 16.1.5.4.1 Key strengths 249 16.1.5.4.2 Strategic choices 249 16.1.5.4.3 Weaknesses and competitive threats 250 16.1.6 CORBION 251 16.1.6.1 Business overview 251 16.1.6.2 Products/Solutions/Services offered 252 16.1.6.3 Recent developments 253 16.1.6.3.1 Product launches and enhancements 253 16.1.6.3.2 Other developments 253 16.1.6.4 MnM view 253 16.1.7 KD PHARMA GROUP SA 254 16.1.7.1 Business overview 254 16.1.7.2 Products/Solutions/Services offered 255 16.1.7.3 Recent developments 257 16.1.7.3.1 Deals 257 16.1.7.3.2 Expansions 257 16.1.7.4 MnM view 258 16.1.8 AKER BIOMARINE 259 16.1.8.1 Business overview 259 16.1.8.2 Products/Solutions/Services offered 260 16.1.8.3 Recent developments 261 16.1.8.3.1 Product launches and enhancements 261 16.1.8.3.2 Expansions 262 16.1.8.3.3 Deals 262 16.1.8.3.4 Other developments 265 16.1.8.4 MnM view 265 16.1.9 CRODA INTERNATIONAL PLC 266 16.1.9.1 Business overview 266 16.1.9.2 Products/Solutions/Services offered 267 16.1.9.3 MnM view 268 16.1.10 EVONIK INDUSTRIES AG 269 16.1.10.1 Business overview 269 16.1.10.2 Products/Solutions/Services offered 270 16.1.10.3 Recent developments 271 16.1.10.3.1 Deals 271 16.1.10.4 MnM view 272 16.1.11 PELAGIA 273 16.1.11.1 Business overview 273 16.1.11.2 Products/Solutions/Services offered 274 16.1.11.3 Recent developments 275 16.1.11.3.1 Product launches and enhancements 275 16.1.11.3.2 Other developments 275 16.1.11.4 MnM view 276 16.1.12 GC RIEBER 277 16.1.12.1 Business overview 277 16.1.12.2 Products/Solutions/Services offered 278 16.1.12.3 Recent developments 279 16.1.12.3.1 Product launches and enhancements 279 16.1.12.3.2 Expansions 279 16.1.12.4 MnM view 280 16.1.13 COOKE AQUACULTURE INC. 281 16.1.13.1 Business overview 281 16.1.13.2 Products/Solutions/Services offered 281 16.1.13.3 Recent developments 283 16.1.13.3.1 Deals 283 16.1.13.4 MnM view 283 16.1.14 ALGISYS BIOSCIENCES, INC. 284 16.1.14.1 Business overview 284 16.1.14.2 Products/Solutions/Services offered 284 16.1.14.3 Recent developments 285 16.1.14.3.1 Other developments 285 16.1.14.4 MnM view 285 16.1.15 POLARIS 286 16.1.15.1 Business overview 286 16.1.15.2 Products/Solutions/Services offered 286 16.1.15.3 Recent developments 287 16.1.15.3.1 Product launches and enhancements 287 16.1.15.3.2 Other developments 287 16.1.15.4 MnM view 287 16.2 OTHER PLAYERS 288 16.2.1 BTSA 288 16.2.1.1 Business overview 288 16.2.1.2 Products/Solutions/Services offered 288 16.2.1.3 MnM view 289 16.2.2 NOVOSANA EUROPE B.V. 290 16.2.2.1 Business overview 290 16.2.2.2 Products/Solutions/Services offered 290 16.2.2.3 MnM view 291 16.2.3 GOLDEN OMEGA 292 16.2.3.1 Business overview 292 16.2.3.2 Products/Solutions/Services offered 292 16.2.3.3 Recent developments 293 16.2.3.3.1 Deals 293 16.2.3.4 MnM view 293 16.2.4 KINOMEGA BIOPHARM INC. 294 16.2.4.1 Business overview 294 16.2.4.2 Products/Solutions/Services offered 294 16.2.4.3 MnM view 295 16.2.5 RIMFROST AS 296 16.2.5.1 Business overview 296 16.2.5.2 Products/Solutions/Services offered 296 16.2.5.3 Recent developments 297 16.2.5.3.1 Deals 297 16.2.5.4 MnM view 297 16.2.6 ALGARITHM 298 16.2.7 SOLUTEX 298 16.2.8 CELLANA INC. 299 16.2.9 SINOMEGA BIOTECH ENGINEERING CO., LTD. 299 16.2.10 ALGAECYTES LIMITED 300 17 RESEARCH METHODOLOGY 301 17.1 RESEARCH DATA 301 17.1.1 SECONDARY DATA 301 17.1.1.1 Key data from secondary sources 302 17.1.2 PRIMARY DATA 302 17.1.2.1 Key data from primary sources 303 17.1.2.2 Breakdown of primary profiles 303 17.1.2.3 Key insights from industry experts 304 17.2 MARKET SIZE ESTIMATION 304 17.2.1 TOP-DOWN APPROACH 305 17.2.2 SUPPLY-SIDE ANALYSIS 306 17.2.3 BOTTOM-UP APPROACH (DEMAND SIDE) 306 17.3 DATA TRIANGULATION AND MARKET BREAKUP 308 17.4 RESEARCH ASSUMPTIONS 309 17.5 RESEARCH LIMITATIONS AND RISK ASSESSMENT 310 18 ADJACENT & RELATED MARKETS 311 18.1 INTRODUCTION 311 18.2 STUDY LIMITATIONS 311 18.3 FUNCTIONAL FOOD INGREDIENTS MARKET 311 18.3.1 MARKET DEFINITION 311 18.3.2 MARKET OVERVIEW 312 18.4 MARINE COLLAGEN MARKET 313 18.4.1 MARKET DEFINITION 313 18.4.2 MARKET OVERVIEW 313 19 APPENDIX 315 19.1 DISCUSSION GUIDE 315 19.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 322 19.3 CUSTOMIZATION OPTIONS 324 19.4 RELATED REPORTS 324 19.5 AUTHOR DETAILS 325

圖表清單 List of Tables & Figures

TABLE 1 INCLUSIONS AND EXCLUSIONS 31 TABLE 2 USD EXCHANGE RATES, 2021–2025 33 TABLE 3 HEALTH BENEFITS ASSOCIATED WITH OMEGA-3 CONSUMPTION 47 TABLE 4 UPCOMING ALTERNATIVE SOURCES FOR OMEGA-3 FATTY ACIDS 54 TABLE 5 KEY MOVES AND STRATEGIC FOCUS 62 TABLE 6 OMEGA-3 MARKET: PORTER’S FIVE FORCES ANALYSIS 64 TABLE 7 OMEGA-3 MARKET: SUPPLY CHAIN (ECOSYSTEM) 71 TABLE 8 AVERAGE SELLING PRICE (ASP) TREND, BY REGION, 2022–2025 (USD/TON) 73 TABLE 9 AVERAGE SELLING PRICE (ASP) TREND, BY SOURCE, 2022–2025 (USD/TON) 74 TABLE 10 TOP IMPORTERS OF OMEGA-3, 2022–2025 (USD) 76 TABLE 11 TOP EXPORTERS OF OMEGA-3, 2022–2025 (USD) 77 TABLE 12 OMEGA-3 MARKET: LIST OF KEY CONFERENCES AND EVENTS, 2026–2027 77 TABLE 13 PATENTS PERTAINING TO OMEGA 3 MARKET, 2021–2026 88 TABLE 14 TOP USE CASES AND MARKET POTENTIAL 92 TABLE 15 BEST PRACTICES: COMPANIES IMPLEMENTING USE CASES 93 TABLE 16 OMEGA 3 MARKET: CASE STUDIES RELATED TO GEN AI IMPLEMENTATION 93 TABLE 17 INTERCONNECTED ADJACENT ECOSYSTEM AND IMPACT ON MARKET PLAYERS 94 TABLE 18 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 96 TABLE 19 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 96 TABLE 20 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 97 TABLE 21 SOUTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 97 TABLE 22 REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 98 TABLE 23 INTERNATIONAL: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 98 TABLE 24 INDUSTRY STANDARDS IN OMEGA-3 MARKET 99 TABLE 25 LABELING REQUIREMENTS AND CLAIMS IN OMEGA-3 MARKET 100 TABLE 26 CERTIFICATIONS, LABELING, AND ECO-STANDARDS IN OMEGA-3 MARKET 104 TABLE 27 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR KEY PRODUCT TYPES 108 TABLE 28 KEY BUYING CRITERIA FOR TOP PRODUCT TYPES 108 TABLE 29 UNMET NEEDS IN OMEGA MARKET, BY APPLICATION INDUSTRIES ACROSS THE SUPPLY CHAIN 110 TABLE 30 COST DYNAMICS IN OMEGA 3 MARKET 112 TABLE 31 OMEGA-3 MARKET, BY TYPE, 2022–2025 (USD MILLION) 116 TABLE 32 OMEGA-3 MARKET, BY TYPE, 2026–2031 (USD MILLION) 116 TABLE 33 FOOD SOURCES FOR DHA (GRAMS PER SERVING) 117 TABLE 34 DOCOSAHEXAENOIC ACID MARKET, BY REGION, 2022–2025 (USD MILLION) 117 TABLE 35 DOCOSAHEXAENOIC ACID MARKET, BY REGION, 2026–2031 (USD MILLION) 118 TABLE 36 FOOD SOURCES FOR EPA (GRAMS PER SERVING) 118 TABLE 37 EICOSAPENTAENOIC ACID MARKET, BY REGION, 2022–2025 (USD MILLION) 119 TABLE 38 EICOSAPENTAENOIC ACID MARKET, BY REGION, 2026–2031 (USD MILLION) 119 TABLE 39 FOOD SOURCES FOR ALA (GRAMS PER SERVING) 120 TABLE 40 ALPHA-LINOLENIC ACID MARKET, BY REGION, 2022–2025 (USD MILLION) 120 TABLE 41 ALPHA-LINOLENIC ACID MARKET, BY REGION, 2026–2031 (USD MILLION) 120 TABLE 42 OMEGA-3 MARKET, BY SOURCE, 2022–2025 (USD MILLION) 122 TABLE 43 OMEGA-3 MARKET, BY SOURCE, 2026–2031 (USD MILLION) 122 TABLE 44 OMEGA-3 MARKET, BY SOURCE, 2022–2025 (KILOTONS) 123 TABLE 45 OMEGA-3 MARKET, BY SOURCE, 2026–2031 (KILOTONS) 123 TABLE 46 MARINE-BASED FOOD SOURCES CONTAINING OMEGA-3 ACIDS 124 TABLE 47 OMEGA-3 MARKET FROM MARINE SOURCES, BY REGION, 2022–2025 (USD MILLION) 124 TABLE 48 OMEGA-3 MARKET FROM MARINE SOURCES, BY REGION, 2026–2031 (USD MILLION) 125 TABLE 49 OMEGA-3 MARKET FROM MARINE SOURCE, BY REGION, 2022–2025 (KILOTONS) 125 TABLE 50 OMEGA-3 MARKET FROM MARINE SOURCES, BY REGION, 2026–2031 (KILOTONS) 125 TABLE 51 OMEGA-3 MARKET FROM MARINE SOURCES, BY SOURCE TYPE, 2022–2025 (USD MILLION) 126 TABLE 52 OMEGA-3 MARKET FROM MARINE SOURCES, BY SOURCE TYPE, 2026–2031 (USD MILLION) 126 TABLE 53 OMEGA-3 MARKET FROM FISH, BY REGION, 2022–2025 (USD MILLION) 126 TABLE 54 OMEGA-3 MARKET FROM FISH, BY REGION, 2026–2031 (USD MILLION) 127 TABLE 55 OMEGA-3 MARKET FROM ALGAE, BY REGION, 2022–2025 (USD MILLION) 128 TABLE 56 OMEGA-3 MARKET FROM ALGAE, BY REGION, 2026–2031 (USD MILLION) 128 TABLE 57 OMEGA-3 MARKET FROM KRILL, BY REGION, 2022–2025 (USD MILLION) 130 TABLE 58 OMEGA-3 MARKET FROM KRILL, BY REGION, 2026–2031 (USD MILLION) 130 TABLE 59 OMEGA-3 MARKET FROM OTHER MARINE SOURCES, BY REGION, 2022–2025 (USD MILLION) 131 TABLE 60 OMEGA-3 MARKET FROM OTHER MARINE SOURCES, BY REGION, 2026–2031 (USD MILLION) 131 TABLE 61 OMEGA-3 MARKET FROM PLANT SOURCES, BY REGION, 2022–2025 (USD MILLION) 132 TABLE 62 OMEGA-3 MARKET FROM PLANT SOURCES, BY REGION, 2026–2031 (USD MILLION) 132 TABLE 63 OMEGA-3 MARKET FROM PLANT SOURCES, BY REGION, 2022–2025 (KILOTONS) 132 TABLE 64 OMEGA-3 MARKET FROM PLANT SOURCES, BY REGION, 2026–2031 (KILOTONS) 133 TABLE 65 OMEGA-3 MARKET FROM PLANT SOURCES, BY SOURCE TYPE, 2022–2025 (USD MILLION) 133 TABLE 66 OMEGA-3 MARKET FROM PLANT SOURCES, BY SOURCE TYPE, 2026–2031 (USD MILLION) 133 TABLE 67 OMEGA-3 MARKET FROM NUTS & SEEDS, BY REGION, 2022–2025 (USD MILLION) 134 TABLE 68 OMEGA-3 MARKET FROM NUTS & SEEDS, BY REGION, 2026–2031 (USD MILLION) 134 TABLE 69 OMEGA-3 MARKET FROM VEGETABLE OILS, BY REGION, 2022–2025 (USD MILLION) 135 TABLE 70 OMEGA-3 MARKET FROM VEGETABLE OILS, BY REGION, 2026–2031 (USD MILLION) 135 TABLE 71 OMEGA-3 MARKET, BY APPLICATION, 2022–2025 (USD MILLION) 137 TABLE 72 OMEGA-3 MARKET, BY APPLICATION, 2026–2031 (USD MILLION) 138 TABLE 73 OMEGA-3 MARKET IN DIETARY SUPPLEMENTS, BY REGION, 2022–2025 (USD MILLION) 139 TABLE 74 OMEGA-3 MARKET IN DIETARY SUPPLEMENTS, BY REGION, 2026–2031 (USD MILLION) 139 TABLE 75 OMEGA-3 MARKET IN FUNCTIONAL FOODS & BEVERAGES, BY REGION, 2022–2025 (USD MILLION) 140 TABLE 76 OMEGA-3 MARKET IN FUNCTIONAL FOODS & BEVERAGES, BY REGION, 2026–2031 (USD MILLION) 140 TABLE 77 OMEGA-3 MARKET IN PHARMACEUTICALS, BY REGION, 2022–2025 (USD MILLION) 142 TABLE 78 OMEGA-3 MARKET IN PHARMACEUTICALS, BY REGION, 2026–2031 (USD MILLION) 143 TABLE 79 OMEGA-3 MARKET IN INFANT FORMULAS, BY REGION, 2022–2025 (USD MILLION) 143 TABLE 80 OMEGA-3 MARKET IN INFANT FORMULAS, BY REGION, 2026–2031 (USD MILLION) 144 TABLE 81 OMEGA-3 MARKET IN PET FOOD & FEED, BY REGION, 2022–2025 (USD MILLION) 144 TABLE 82 OMEGA-3 MARKET IN PET FOOD & FEED, BY REGION, 2026–2031 (USD MILLION) 145 TABLE 83 OMEGA-3 MARKET, BY FORM, 2022–2025 (USD MILLION) 147 TABLE 84 OMEGA-3 MARKET, BY FORM, 2026–2031 (USD MILLION) 147 TABLE 85 DRY OMEGA-3 MARKET, BY REGION, 2022–2025 (USD MILLION) 148 TABLE 86 DRY OMEGA-3 MARKET, BY REGION, 2026–2031 (USD MILLION) 148 TABLE 87 LIQUID OMEGA-3 MARKET, BY REGION, 2022–2025 (USD MILLION) 149 TABLE 88 LIQUID OMEGA-3 MARKET, BY REGION, 2026–2031 (USD MILLION) 150 TABLE 89 OMEGA-3 MARKET, BY REGION, 2022–2025 (USD MILLION) 156 TABLE 90 OMEGA-3 MARKET, BY REGION, 2026–2031 (USD MILLION) 157 TABLE 91 OMEGA-3 MARKET, BY REGION, 2022–2025 (KILOTONS) 157 TABLE 92 OMEGA-3 MARKET, BY REGION, 2026–2031 (KILOTONS) 157 TABLE 93 NORTH AMERICA: OMEGA-3 MARKET, BY COUNTRY, 2022–2025 (USD MILLION) 159 TABLE 94 NORTH AMERICA: OMEGA-3 MARKET, BY COUNTRY, 2026–2031 (USD MILLION) 159 TABLE 95 NORTH AMERICA: OMEGA-3 MARKET, BY TYPE, 2022–2025 (USD MILLION) 160 TABLE 96 NORTH AMERICA: OMEGA-3 MARKET, BY TYPE, 2026–2031 (USD MILLION) 160 TABLE 97 NORTH AMERICA: OMEGA-3 MARKET, BY APPLICATION, 2022–2025 (USD MILLION) 160 TABLE 98 NORTH AMERICA: OMEGA-3 MARKET, BY APPLICATION, 2026–2031 (USD MILLION) 160 TABLE 99 NORTH AMERICA: OMEGA-3 MARKET, BY SOURCE, 2022–2025 (USD MILLION) 161 TABLE 100 NORTH AMERICA: OMEGA-3 MARKET, BY SOURCE, 2026–2031 (USD MILLION) 161 TABLE 101 NORTH AMERICA: OMEGA-3 MARKET, BY SOURCE, 2022–2025 (KILOTONS) 161 TABLE 102 NORTH AMERICA: OMEGA-3 MARKET, BY SOURCE, 2026–2031 (KILOTONS) 161 TABLE 103 NORTH AMERICA: MARINE OMEGA-3 MARKET, BY SOURCE TYPE, 2022–2025 (USD MILLION) 162 TABLE 104 NORTH AMERICA: MARINE OMEGA-3 MARKET, BY SOURCE TYPE, 2026–2031 (USD MILLION) 162 TABLE 105 NORTH AMERICA: PLANT OMEGA-3 MARKET, BY SOURCE TYPE, 2022–2025 (USD MILLION) 162 TABLE 106 NORTH AMERICA: PLANT OMEGA-3 MARKET, BY SOURCE TYPE, 2026–2031 (USD MILLION) 162 TABLE 107 US: OMEGA-3 MARKET, BY TYPE, 2022–2025 (USD MILLION) 163 TABLE 108 US: OMEGA-3 MARKET, BY TYPE, 2026–2031 (USD MILLION) 163 TABLE 109 US: OMEGA-3 MARKET, BY SOURCE, 2022–2025 (USD MILLION) 164 TABLE 110 US: OMEGA-3 MARKET, BY SOURCE, 2026–2031 (USD MILLION) 164 TABLE 111 CANADA: OMEGA-3 MARKET, BY TYPE, 2022–2025 (USD MILLION) 165 TABLE 112 CANADA: OMEGA-3 MARKET, BY TYPE, 2026–2031 (USD MILLION) 165 TABLE 113 CANADA: OMEGA-3 MARKET, BY SOURCE, 2022–2025 (USD MILLION) 165 TABLE 114 CANADA: OMEGA-3 MARKET, BY SOURCE, 2026–2031 (USD MILLION) 165 TABLE 115 MEXICO: OMEGA-3 MARKET, BY TYPE, 2022–2025 (USD MILLION) 166 TABLE 116 MEXICO: OMEGA-3 MARKET, BY TYPE, 2026–2031 (USD MILLION) 167 TABLE 117 MEXICO: OMEGA-3 MARKET, BY SOURCE, 2022–2025 (USD MILLION) 167 TABLE 118 MEXICO: OMEGA-3 MARKET, BY SOURCE, 2026–2031 (USD MILLION) 167 TABLE 119 EUROPE: OMEGA-3 MARKET, BY COUNTRY, 2022–2025 (USD MILLION) 168 TABLE 120 EUROPE: OMEGA-3 MARKET, BY COUNTRY, 2026–2031 (USD MILLION) 169 TABLE 121 EUROPE: OMEGA-3 MARKET, BY TYPE, 2022–2025 (USD MILLION) 169 TABLE 122 EUROPE: OMEGA-3 MARKET, BY TYPE, 2026–2031 (USD MILLION) 169 TABLE 123 EUROPE: OMEGA-3 MARKET, BY APPLICATION, 2022–2025 (USD MILLION) 170 TABLE 124 EUROPE: OMEGA-3 MARKET, BY APPLICATION, 2026–2031 (USD MILLION) 170 TABLE 125 EUROPE: OMEGA-3 MARKET, BY SOURCE, 2022–2025 (USD MILLION) 170 TABLE 126 EUROPE: OMEGA-3 MARKET, BY SOURCE, 2026–2031 (USD MILLION) 170 TABLE 127 EUROPE: OMEGA-3 MARKET, BY SOURCE, 2022–2025 (KILOTONS) 171 TABLE 128 EUROPE: OMEGA-3 MARKET, BY SOURCE, 2026–2031 (KILOTONS) 171 TABLE 129 EUROPE: MARINE OMEGA-3 MARKET, BY SOURCE TYPE, 2022–2025 (USD MILLION) 171 TABLE 130 EUROPE: MARINE OMEGA-3 MARKET, BY SOURCE TYPE, 2026–2031 (USD MILLION) 171 TABLE 131 EUROPE: PLANT OMEGA-3 MARKET, BY SOURCE TYPE, 2022–2025 (USD MILLION) 172 TABLE 132 EUROPE: PLANT OMEGA-3 MARKET, BY SOURCE TYPE, 2026–2031 (USD MILLION) 172 TABLE 133 GERMANY: OMEGA-3 MARKET, BY TYPE, 2022–2025 (USD MILLION) 172 TABLE 134 GERMANY: OMEGA-3 MARKET, BY TYPE, 2026–2031 (USD MILLION) 173 TABLE 135 GERMANY: OMEGA-3 MARKET, BY SOURCE, 2022–2025 (USD MILLION) 173 TABLE 136 GERMANY: OMEGA-3 MARKET, BY SOURCE, 2026–2031 (USD MILLION) 173 TABLE 137 UK: OMEGA-3 MARKET, BY TYPE, 2022–2025 (USD MILLION) 174 TABLE 138 UK: OMEGA-3 MARKET, BY TYPE, 2026–2031 (USD MILLION) 174 TABLE 139 UK: OMEGA-3 MARKET, BY SOURCE, 2022–2025 (USD MILLION) 174 TABLE 140 UK: OMEGA-3 MARKET, BY SOURCE, 2026–2031 (USD MILLION) 175 TABLE 141 FRANCE: OMEGA-3 MARKET, BY TYPE, 2022–2025 (USD MILLION) 176 TABLE 142 FRANCE: OMEGA-3 MARKET, BY TYPE, 2026–2031 (USD MILLION) 176 TABLE 143 FRANCE: OMEGA-3 MARKET, BY SOURCE, 2022–2025 (USD MILLION) 176 TABLE 144 FRANCE: OMEGA-3 MARKET, BY SOURCE, 2026–2031 (USD MILLION) 176 TABLE 145 NORWAY: OMEGA-3 MARKET, BY TYPE, 2022–2025 (USD MILLION) 177 TABLE 146 NORWAY: OMEGA-3 MARKET, BY TYPE, 2026–2031 (USD MILLION) 177 TABLE 147 NORWAY: OMEGA-3 MARKET, BY SOURCE, 2022–2025 (USD MILLION) 177 TABLE 148 NORWAY: OMEGA-3 MARKET, BY SOURCE, 2026–2031 (USD MILLION) 178 TABLE 149 ITALY: OMEGA-3 MARKET, BY TYPE, 2022–2025 (USD MILLION) 178 TABLE 150 ITALY: OMEGA-3 MARKET, BY TYPE, 2026–2031 (USD MILLION) 179 TABLE 151 ITALY: OMEGA-3 MARKET, BY SOURCE, 2022–2025 (USD MILLION) 179 TABLE 152 ITALY: OMEGA-3 MARKET, BY SOURCE, 2026–2031 (USD MILLION) 179 TABLE 153 SPAIN: OMEGA-3 MARKET, BY TYPE, 2022–2025 (USD MILLION) 180 TABLE 154 SPAIN: OMEGA-3 MARKET, BY TYPE, 2026–2031 (USD MILLION) 180 TABLE 155 SPAIN: OMEGA-3 MARKET, BY SOURCE, 2022–2025 (USD MILLION) 180 TABLE 156 SPAIN: OMEGA-3 MARKET, BY SOURCE, 2026–2031 (USD MILLION) 181 TABLE 157 NETHERLANDS: OMEGA-3 MARKET, BY TYPE, 2022–2025 (USD MILLION) 181 TABLE 158 NETHERLANDS: OMEGA-3 MARKET, BY TYPE, 2026–2031 (USD MILLION) 182 TABLE 159 NETHERLANDS: OMEGA-3 MARKET, BY SOURCE, 2022–2025 (USD MILLION) 182 TABLE 160 NETHERLANDS: OMEGA-3 MARKET, BY SOURCE, 2026–2031 (USD MILLION) 182 TABLE 161 REST OF EUROPE: OMEGA-3 MARKET, BY TYPE, 2022–2025 (USD MILLION) 183 TABLE 162 REST OF EUROPE: OMEGA-3 MARKET, BY TYPE, 2026–2031 (USD MILLION) 183 TABLE 163 REST OF EUROPE: OMEGA-3 MARKET, BY SOURCE, 2022–2025 (USD MILLION) 183 TABLE 164 REST OF EUROPE: OMEGA-3 MARKET, BY SOURCE, 2026–2031 (USD MILLION) 183 TABLE 165 ASIA PACIFIC: OMEGA-3 MARKET, BY COUNTRY, 2022–2025 (USD MILLION) 185 TABLE 166 ASIA PACIFIC: OMEGA-3 MARKET, BY COUNTRY, 2026–2031 (USD MILLION) 186 TABLE 167 ASIA PACIFIC: OMEGA-3 MARKET, BY TYPE, 2022–2025 (USD MILLION) 186 TABLE 168 ASIA PACIFIC: OMEGA-3 MARKET, BY TYPE, 2026–2031 (USD MILLION) 186 TABLE 169 ASIA PACIFIC: OMEGA-3 MARKET, BY APPLICATION, 2022–2025 (USD MILLION) 187 TABLE 170 ASIA PACIFIC: OMEGA-3 MARKET, BY APPLICATION, 2026–2031 (USD MILLION) 187 TABLE 171 ASIA PACIFIC: OMEGA-3 MARKET, BY SOURCE, 2022–2025 (USD MILLION) 187 TABLE 172 ASIA PACIFIC: OMEGA-3 MARKET, BY SOURCE, 2026–2031 (USD MILLION) 187 TABLE 173 ASIA PACIFIC: OMEGA-3 MARKET, BY SOURCE, 2022–2025 (KILOTONS) 188 TABLE 174 ASIA PACIFIC: OMEGA-3 MARKET, BY SOURCE, 2026–2031 (KILOTONS) 188 TABLE 175 ASIA PACIFIC: MARINE OMEGA-3 MARKET, BY SOURCE TYPE, 2022–2025 (USD MILLION) 188 TABLE 176 ASIA PACIFIC: MARINE OMEGA-3 MARKET, BY SOURCE TYPE, 2026–2031 (USD MILLION) 188 TABLE 177 ASIA PACIFIC: PLANT OMEGA-3 MARKET, BY SOURCE TYPE, 2022–2025 (USD MILLION) 189 TABLE 178 ASIA PACIFIC: PLANT OMEGA-3 MARKET, BY SOURCE TYPE, 2026–2031 (USD MILLION) 189 TABLE 179 CHINA: OMEGA-3 MARKET, BY TYPE, 2022–2025 (USD MILLION) 190 TABLE 180 CHINA: OMEGA-3 MARKET, BY TYPE, 2026–2031 (USD MILLION) 190 TABLE 181 CHINA: OMEGA-3 MARKET, BY SOURCE, 2022–2025 (USD MILLION) 190 TABLE 182 CHINA: OMEGA-3 MARKET, BY SOURCE, 2026–2031 (USD MILLION) 190 TABLE 183 INDIA: OMEGA-3 MARKET, BY TYPE, 2022–2025 (USD MILLION) 191 TABLE 184 INDIA: OMEGA-3 MARKET, BY TYPE, 2026–2031 (USD MILLION) 191 TABLE 185 INDIA: OMEGA-3 MARKET, BY SOURCE, 2022–2025 (USD MILLION) 192 TABLE 186 INDIA: OMEGA-3 MARKET, BY SOURCE, 2026–2031 (USD MILLION) 192 TABLE 187 JAPAN: OMEGA-3 MARKET, BY TYPE, 2022–2025 (USD MILLION) 193 TABLE 188 JAPAN: OMEGA-3 MARKET, BY TYPE, 2026–2031 (USD MILLION) 193 TABLE 189 JAPAN: OMEGA-3 MARKET, BY SOURCE, 2022–2025 (USD MILLION) 193 TABLE 190 JAPAN: OMEGA-3 MARKET, BY SOURCE, 2026–2031 (USD MILLION) 193 TABLE 191 AUSTRALIA & NEW ZEALAND: OMEGA-3 MARKET, BY TYPE, 2022–2025 (USD MILLION) 195 TABLE 192 AUSTRALIA & NEW ZEALAND: OMEGA-3 MARKET, BY TYPE, 2026–2031 (USD MILLION) 195 TABLE 193 AUSTRALIA & NEW ZEALAND: OMEGA-3 MARKET, BY SOURCE, 2022–2025 (USD MILLION) 195 TABLE 194 AUSTRALIA & NEW ZEALAND: OMEGA-3 MARKET, BY SOURCE, 2026–2031 (USD MILLION) 195 TABLE 195 REST OF ASIA PACIFIC: OMEGA-3 MARKET, BY TYPE, 2022–2025 (USD MILLION) 196 TABLE 196 REST OF ASIA PACIFIC: OMEGA-3 MARKET, BY TYPE, 2026–2031 (USD MILLION) 196 TABLE 197 REST OF ASIA PACIFIC: OMEGA-3 MARKET, BY SOURCE, 2022–2025 (USD MILLION) 197 TABLE 198 REST OF ASIA PACIFIC: OMEGA-3 MARKET, BY SOURCE, 2026–2031 (USD MILLION) 197 TABLE 199 SOUTH AMERICA: OMEGA-3 MARKET, BY COUNTRY, 2022–2025 (USD MILLION) 198 TABLE 200 SOUTH AMERICA: OMEGA-3 MARKET, BY COUNTRY, 2026–2031 (USD MILLION) 198 TABLE 201 SOUTH AMERICA: OMEGA-3 MARKET, BY TYPE, 2022–2025 (USD MILLION) 198 TABLE 202 SOUTH AMERICA: OMEGA-3 MARKET, BY TYPE, 2026–2031 (USD MILLION) 198 TABLE 203 SOUTH AMERICA: OMEGA-3 MARKET, BY APPLICATION, 2022–2025 (USD MILLION) 199 TABLE 204 SOUTH AMERICA: OMEGA-3 MARKET, BY APPLICATION, 2026–2031 (USD MILLION) 199 TABLE 205 SOUTH AMERICA: OMEGA-3 MARKET, BY SOURCE, 2022–2025 (USD MILLION) 199 TABLE 206 SOUTH AMERICA: OMEGA-3 MARKET, BY SOURCE, 2026–2031 (USD MILLION) 199 TABLE 207 SOUTH AMERICA: OMEGA-3 MARKET, BY SOURCE, 2022–2025 (KILOTONS) 200 TABLE 208 SOUTH AMERICA: OMEGA-3 MARKET, BY SOURCE, 2026–2031 (KILOTONS) 200 TABLE 209 SOUTH AMERICA: MARINE OMEGA-3 MARKET, BY SOURCE TYPE, 2022–2025 (USD MILLION) 200 TABLE 210 SOUTH AMERICA: MARINE OMEGA-3 MARKET, BY SOURCE TYPE, 2026–2031 (USD MILLION) 200 TABLE 211 SOUTH AMERICA: PLANT OMEGA-3 MARKET, BY SOURCE TYPE, 2022–2025 (USD MILLION) 201 TABLE 212 SOUTH AMERICA: PLANT OMEGA-3 MARKET, BY SOURCE TYPE, 2026–2031 (USD MILLION) 201 TABLE 213 BRAZIL: OMEGA-3 MARKET, BY TYPE, 2022–2025 (USD MILLION) 202 TABLE 214 BRAZIL: OMEGA-3 MARKET, BY TYPE, 2026–2031 (USD MILLION) 202 TABLE 215 BRAZIL: OMEGA-3 MARKET, BY SOURCE, 2022–2025 (USD MILLION) 202 TABLE 216 BRAZIL: OMEGA-3 MARKET, BY SOURCE, 2026–2031 (USD MILLION) 202 TABLE 217 ARGENTINA: OMEGA-3 MARKET, BY TYPE, 2022–2025 (USD MILLION) 203 TABLE 218 ARGENTINA: OMEGA-3 MARKET, BY TYPE, 2026–2031 (USD MILLION) 203 TABLE 219 ARGENTINA: OMEGA-3 MARKET, BY SOURCE, 2022–2025 (USD MILLION) 203 TABLE 220 ARGENTINA: OMEGA-3 MARKET, BY SOURCE, 2026–2031 (USD MILLION) 204 TABLE 221 REST OF SOUTH AMERICA: OMEGA-3 MARKET, BY TYPE, 2022–2025 (USD MILLION) 204 TABLE 222 REST OF SOUTH AMERICA: OMEGA-3 MARKET, BY TYPE, 2026–2031 (USD MILLION) 204 TABLE 223 REST OF SOUTH AMERICA: OMEGA-3 MARKET, BY SOURCE, 2022–2025 (USD MILLION) 204 TABLE 224 REST OF SOUTH AMERICA: OMEGA-3 MARKET, BY SOURCE, 2026–2031 (USD MILLION) 205 TABLE 225 ROW: OMEGA-3 MARKET, BY REGION, 2022–2025 (USD MILLION) 205 TABLE 226 ROW: OMEGA-3 MARKET, BY REGION, 2026–2031 (USD MILLION) 205 TABLE 227 ROW: OMEGA-3 MARKET, BY TYPE, 2022–2025 (USD MILLION) 206 TABLE 228 ROW: OMEGA-3 MARKET, BY TYPE, 2026–2031 (USD MILLION) 206 TABLE 229 ROW: OMEGA-3 MARKET, BY APPLICATION, 2022–2025 (USD MILLION) 206 TABLE 230 ROW: OMEGA-3 MARKET, BY APPLICATION, 2026–2031 (USD MILLION) 207 TABLE 231 ROW: OMEGA-3 MARKET, BY SOURCE, 2022–2025 (USD MILLION) 207 TABLE 232 ROW: OMEGA-3 MARKET, BY SOURCE, 2026–2031 (USD MILLION) 207 TABLE 233 ROW: OMEGA-3 MARKET, BY SOURCE, 2022–2025 (KILOTONS) 207 TABLE 234 ROW: OMEGA-3 MARKET, BY SOURCE, 2026–2031 (KILOTONS) 208 TABLE 235 ROW: MARINE OMEGA-3 MARKET, BY SOURCE TYPE, 2022–2025 (USD MILLION) 208 TABLE 236 ROW: MARINE OMEGA-3 MARKET, BY SOURCE TYPE, 2026–2031 (USD MILLION) 208 TABLE 237 ROW: PLANT OMEGA-3 MARKET, BY SOURCE TYPE, 2022–2025 (USD MILLION) 208 TABLE 238 ROW: PLANT OMEGA-3 MARKET, BY SOURCE TYPE, 2026–2031 (USD MILLION) 209 TABLE 239 AFRICA: OMEGA-3 MARKET, BY TYPE, 2022–2025 (USD MILLION) 209 TABLE 240 AFRICA: OMEGA-3 MARKET, BY TYPE, 2026–2031 (USD MILLION) 210 TABLE 241 AFRICA: OMEGA-3 MARKET, BY SOURCE, 2022–2025 (USD MILLION) 210 TABLE 242 AFRICA: OMEGA-3 MARKET, BY SOURCE, 2026–2031 (USD MILLION) 210 TABLE 243 MIDDLE EAST: OMEGA-3 MARKET, BY TYPE, 2022–2025 (USD MILLION) 211 TABLE 244 MIDDLE EAST: OMEGA-3 MARKET, BY TYPE, 2026–2031 (USD MILLION) 211 TABLE 245 MIDDLE EAST: OMEGA-3 MARKET, BY SOURCE, 2022–2025 (USD MILLION) 211 TABLE 246 MIDDLE EAST: OMEGA-3 MARKET, BY SOURCE, 2026–2031 (USD MILLION) 211 TABLE 247 OVERVIEW OF STRATEGIES ADOPTED BY KEY OMEGA-3 MARKET PLAYERS 213 TABLE 248 OMEGA-3 MARKET: MARKET SHARE ANALYSIS, 2025 216 TABLE 249 OMEGA-3 MARKET: REGIONAL FOOTPRINT, 2024 223 TABLE 250 OMEGA-3 MARKET: SOURCE FOOTPRINT, 2024 224 TABLE 251 OMEGA-3 MARKET: TYPE FOOTPRINT, 2024 225 TABLE 252 OMEGA-3 MARKET: APPLICATION FOOTPRINT, 2024 225 TABLE 253 OMEGA-3 MARKET: DETAILED LIST OF KEY STARTUPS/SMES 228 TABLE 254 OMEGA-3 MARKET: COMPETITIVE BENCHMARKING OF STARTUPS/SMES 229 TABLE 255 OMEGA-3 MARKET: PRODUCT LAUNCHES, JUNE 2022–JULY 2026 230 TABLE 256 OMEGA-3 MARKET: DEALS, DECEMBER 2022–JULY 2026 231 TABLE 257 OMEGA-3 MARKET: EXPANSIONS, FEBRUARY 2020–JULY 2026 233 TABLE 258 DSM-FIRMENICH: COMPANY OVERVIEW 234 TABLE 259 DSM-FIRMENICH: PRODUCTS/SOLUTIONS/SERVICES OFFERED 235 TABLE 260 DSM-FIRMENICH: PRODUCT LAUNCHES AND ENHANCEMENTS 236 TABLE 261 CARGILL, INCORPORATED: COMPANY OVERVIEW 238 TABLE 262 CARGILL, INCORPORATED: PRODUCTS/SOLUTIONS/SERVICES OFFERED 239 TABLE 263 CARGILL, INCORPORATED: DEALS 240 TABLE 264 BASF SE: COMPANY OVERVIEW 241 TABLE 265 BASF SE: PRODUCTS/SOLUTIONS/SERVICES OFFERED 242 TABLE 266 BASF SE: DEALS 243 TABLE 267 ADM: COMPANY OVERVIEW 244 TABLE 268 ADM: PRODUCTS/SOLUTIONS/SERVICES OFFERED 245 TABLE 269 KERRY GROUP PLC: COMPANY OVERVIEW 247 TABLE 270 KERRY GROUP PLC: PRODUCTS/SOLUTIONS/SERVICES OFFERED 248 TABLE 271 KERRY GROUP PLC: DEALS 249 TABLE 272 CORBION: COMPANY OVERVIEW 251 TABLE 273 CORBION: PRODUCTS/SOLUTIONS/SERVICES OFFERED 252 TABLE 274 CORBION: PRODUCT LAUNCHES AND ENHANCEMENTS 253 TABLE 275 CORBION: OTHER DEVELOPMENTS 253 TABLE 276 KD PHARMA GROUP SA: COMPANY OVERVIEW 254 TABLE 277 KD PHARMA GROUP SA: PRODUCTS/SOLUTIONS/SERVICES OFFERED 255 TABLE 278 KD PHARMA GROUP SA: DEALS 257 TABLE 279 KD PHARMA GROUP SA: EXPANSIONS 257 TABLE 280 AKER BIOMARINE: COMPANY OVERVIEW 259 TABLE 281 AKER BIOMARINE: PRODUCTS/SOLUTIONS/SERVICES OFFERED 260 TABLE 282 AKER BIOMARINE: PRODUCT LAUNCHES AND ENHANCEMENTS 261 TABLE 283 AKER BIOMARINE: EXPANSIONS 262 TABLE 284 AKER BIOMARINE: DEALS 262 TABLE 285 AKER BIOMARINE: OTHER DEVELOPMENTS 265 TABLE 286 CRODA INTERNATIONAL PLC: COMPANY OVERVIEW 266 TABLE 287 CRODA INTERNATIONAL PLC: PRODUCTS/SOLUTIONS/SERVICES OFFERED 267 TABLE 288 EVONIK INDUSTRIES AG: COMPANY OVERVIEW 269 TABLE 289 EVONIK INDUSTRIES AG: PRODUCTS/SOLUTIONS/SERVICES OFFERED 270 TABLE 290 EVONIK INDUSTRIES AG: DEALS 271 TABLE 291 PELAGIA: COMPANY OVERVIEW 273 TABLE 292 PELAGIA: PRODUCTS/SOLUTIONS/SERVICES OFFERED 274 TABLE 293 PELAGIA: PRODUCT LAUNCHES AND ENHANCEMENTS 275 TABLE 294 PELAGIA AS: OTHER DEVELOPMENTS 275 TABLE 295 GC RIEBER: COMPANY OVERVIEW 277 TABLE 296 GC RIEBER: PRODUCTS/SOLUTIONS/SERVICES OFFERED 278 TABLE 297 GC RIEBER: PRODUCT LAUNCHES AND ENHANCEMENTS 279 TABLE 298 GC RIEBER: EXPANSIONS 279 TABLE 299 COOKE AQUACULTURE INC.: COMPANY OVERVIEW 281 TABLE 300 COOKE AQUACULTURE INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED 281 TABLE 301 COOKE AQUACULTURE INC.: DEALS 283 TABLE 302 ALGISYS BIOSCIENCES, INC.: COMPANY OVERVIEW 284 TABLE 303 ALGISYS BIOSCIENCES, INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED 284 TABLE 304 ALGISYS BIOSCIENCES, INC.: OTHER DEVELOPMENTS 285 TABLE 305 POLARIS: COMPANY OVERVIEW 286 TABLE 306 POLARIS: PRODUCTS/SOLUTIONS/SERVICES OFFERED 286 TABLE 307 POLARIS: PRODUCT LAUNCHES AND ENHANCEMENTS 287 TABLE 308 POLARIS: OTHER DEVELOPMENTS 287 TABLE 309 BTSA: COMPANY OVERVIEW 288 TABLE 310 BTSA: PRODUCTS/SOLUTIONS/SERVICES OFFERED 288 TABLE 311 NOVOSANA EUROPE B.V.: COMPANY OVERVIEW 290 TABLE 312 NOVOSANA EUROPE B.V.: PRODUCTS/SOLUTIONS/SERVICES OFFERED 290 TABLE 313 GOLDEN OMEGA: COMPANY OVERVIEW 292 TABLE 314 GOLDEN OMEGA: PRODUCTS/SOLUTIONS/SERVICES OFFERED 292 TABLE 315 GOLDEN OMEGA: DEALS 293 TABLE 316 KINOMEGA BIOPHARM INC.: COMPANY OVERVIEW 294 TABLE 317 KINOMEGA BIOPHARM INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED 294 TABLE 318 RIMFROST AS: COMPANY OVERVIEW 296 TABLE 319 RIMFROST AS: PRODUCTS/SOLUTIONS/SERVICES OFFERED 296 TABLE 320 RIMFROST AS: DEALS 297 TABLE 321 MARKETS ADJACENT TO OMEGA-3 MARKET 311 TABLE 322 FUNCTIONAL FOOD INGREDIENTS MARKET, BY SOURCE, 2019–2023 (USD MILLION) 312 TABLE 323 FUNCTIONAL FOOD INGREDIENTS MARKET, BY SOURCE, 2024–2029 (USD MILLION) 312 TABLE 324 MARINE COLLAGEN MARKET, BY FORM, 2022–2025 (USD MILLION) 313 TABLE 325 MARINE COLLAGEN MARKET, BY FORM, 2026–2031 (USD MILLION) 314 FIGURE 1 OMEGA-3 MARKETS COVERED 30 FIGURE 2 STUDY YEARS CONSIDERED 32 FIGURE 3 MARKET SCENARIO 35 FIGURE 4 OMEGA-3 MARKET, 2022–2031 36 FIGURE 5 MAJOR STRATEGIES ADOPTED BY KEY PLAYERS IN OMEGA-3 MARKET, JULY 2021–MAY 2026 37 FIGURE 6 DISRUPTIONS INFLUENCING GROWTH OF OMEGA-3 MARKET 38 FIGURE 7 OMEGA-3 MARKET: HIGH-GROWTH SEGMENTS, 2026–2031 39 FIGURE 8 ASIA PACIFIC TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD 40 FIGURE 9 INCREASING DEMAND FOR OMEGA-3 ACROSS FUNCTIONAL FOODS AND DIETARY SUPPLEMENTS TO SUPPORT MARKET GROWTH 41 FIGURE 10 TYPE SEGMENT DOCOSAHEXAENOIC ACID (DHA) AND NORTH AMERICA REGION TO ACCOUNT FOR LARGEST MARKET SHARES IN 2026 42 FIGURE 11 OMEGA-3 DOCOSAHEXAENOIC ACID (DHA) TYPE SEGMENT TO LEAD MARKET IN 2026 42 FIGURE 12 MARINE SEGMENT TO ACCOUNT FOR LARGEST MARKET SHARE IN 2026 43 FIGURE 13 BY FORM SEGMENT DRY FORM SEGMENT TO DOMINATE MARKET IN 2026 43 FIGURE 14 DIETARY SUPPLEMENTS APPLICATION SEGMENT TO DOMINATE MARKET IN 2026 43 FIGURE 15 US TO ACCOUNT FOR LARGEST MARKET SHARE IN 2026 44 FIGURE 16 OMEGA-3 MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 46 FIGURE 17 RECOMMENDED EPA LEVELS IN DOG FOOD (MG) 50 FIGURE 18 MICROALGAE PROCESSING FOR OMEGA-3 55 FIGURE 19 OMEGA-3 MARKET: PORTER’S FIVE FORCES ANALYSIS 63 FIGURE 20 PREVENTIVE HEALTHCARE EXPENDITURE AS PERCENTAGE OF GDP, BY COUNTRY, 2023 66 FIGURE 21 GLOBAL POPULATION AGED 65 AND ABOVE (% OF TOTAL POPULATION), 2014–2025 67 FIGURE 22 OMEGA-3 MARKET: VALUE CHAIN ANALYSIS 68 FIGURE 23 OMEGA-3 MARKET ECOSYSTEM MAP 71 FIGURE 24 AVERAGE SELLING PRICE OF OMEGA-3 FINISHED PRODUCTS, BY PRODUCT TYPE, 2025 (USD) 73 FIGURE 25 AVERAGE SELLING PRICE (ASP) TREND, BY REGION, 2022–2025 (USD/TON) 74 FIGURE 26 IMPORT OF HS CODE 1504, BY KEY COUNTRY, 2022–2025 (USD) 75 FIGURE 27 EXPORT OF HS CODE 1504, BY KEY COUNTRY, 2022–2025 (USD) 76 FIGURE 28 TRENDS/DISRUPTIONS INFLUENCING CUSTOMERS’ BUSINESSES 78 FIGURE 29 INVESTMENT AND FUNDING SCENARIO 78 FIGURE 30 NUMBER OF PATENTS GRANTED BETWEEN 2016 AND 2026 88 FIGURE 31 FUTURE APPLICATIONS 89 FIGURE 32 OMEGA-3 MARKET DECISION-MAKING FACTORS 106 FIGURE 33 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR KEY PRODUCT TYPES 107 FIGURE 34 KEY BUYING CRITERIA FOR TOP PRODUCT TYPES 108 FIGURE 35 ADOPTION BARRIERS AND INTERNAL CHALLENGES 109 FIGURE 36 OMEGA-3 MARKET, BY TYPE, 2026 VS. 2031 (USD MILLION) 115 FIGURE 37 OMEGA-3 MARKET, BY SOURCE, 2026 VS. 2031 (USD MILLION) 122 FIGURE 38 OMEGA-3 MARKET, BY APPLICATION, 2026 VS. 2031 (USD MILLION) 137 FIGURE 39 OMEGA-3 MARKET, BY FORM, 2026 VS. 2031 (USD MILLION) 147 FIGURE 40 INDIA TO RECORD HIGHEST GROWTH RATE IN THE OMEGA-3 MARKET 156 FIGURE 41 NORTH AMERICA: REGIONAL SNAPSHOT 159 FIGURE 42 ASIA PACIFIC: REGIONAL SNAPSHOT 185 FIGURE 43 REVENUE ANALYSIS OF KEY PLAYERS, 2023–2025 (USD BILLION) 215 FIGURE 44 OMEGA-3 MARKET SHARE ANALYSIS, 2025 216 FIGURE 45 COMPANY VALUATION FOR MAJOR PLAYERS IN OMEGA-3 MARKET 218 FIGURE 46 EV/EBITDA OF MAJOR PLAYERS 218 FIGURE 47 OMEGA-3 MARKET: BRAND/PRODUCT COMPARISON 219 FIGURE 48 OMEGA-3 MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2025 222 FIGURE 49 OMEGA-3 MARKET: COMPANY FOOTPRINT, 2024 223 FIGURE 50 OMEGA-3 MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2024 227 FIGURE 51 DSM-FIRMENICH: COMPANY SNAPSHOT 235 FIGURE 52 CARGILL, INCORPORATED: COMPANY SNAPSHOT 239 FIGURE 53 BASF SE: COMPANY SNAPSHOT 242 FIGURE 54 ADM: COMPANY SNAPSHOT 245 FIGURE 55 KERRY GROUP PLC: COMPANY SNAPSHOT 248 FIGURE 56 CORBION: COMPANY SNAPSHOT 252 FIGURE 57 KD PHARMA GROUP SA: COMPANY SNAPSHOT 255 FIGURE 58 AKER BIOMARINE: COMPANY SNAPSHOT 260 FIGURE 59 CRODA INTERNATIONAL PLC: COMPANY SNAPSHOT 267 FIGURE 60 EVONIK INDUSTRIES AG: COMPANY SNAPSHOT 270 FIGURE 61 PELAGIA: COMPANY SNAPSHOT 274 FIGURE 62 GC RIEBER: COMPANY SNAPSHOT 278 FIGURE 63 OMEGA-3 MARKET: RESEARCH DESIGN 301 FIGURE 64 BREAKDOWN OF PRIMARY INTERVIEWS, BY COMPANY TYPE, DESIGNATION, AND REGION 303 FIGURE 65 MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH 305 FIGURE 66 SUPPLY-SIDE ANALYSIS: SOURCES OF INFORMATION AT EVERY STEP 306 FIGURE 67 OMEGA-3 MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH 307 FIGURE 68 DATA TRIANGULATION 308

常見問題

這份報告可以先索取樣本嗎？

可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。

報告價格如何計算？

報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。

下單後多久交付？如何付款？

一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。

量子訊息有限公司為 MarketsandMarkets 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・聯絡我們